PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

NARecruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

June 30, 2028

Conditions
Opioid Use Disorder
Interventions
BEHAVIORAL

CHORUS+

The CHORUS+ intervention will include a baseline interview with a peer recovery coach to encourage uptake of HIV PrEP (pre-exposure prophylaxis) and medications for opioid use disorder (MOUD) through motivational interviewing (MI). Participants will also be offered HIV self-testing on the day of recruitment, HIV PrEP (if they are HIV negative) and MOUD. Participants will then receive peer coaching for 6 months to increase adherence to PrEP and or MOUD.

OTHER

Standard of care

Normal protocols for care of participants who inject opioids will be followed.

Trial Locations (2)

02118

RECRUITING

Boston Medical Center Faster Paths Bridge Clinic, Boston

RECRUITING

Victory Programs Mobile Prevention Services Van and Navigation Center, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Victory Programs Mobile Prevention Services Van and Navigation Center

UNKNOWN

lead

Boston Medical Center

OTHER